| skin development | GO:0043588 | 220 | 0.148 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.140 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.134 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.131 | |
| gland development | GO:0048732 | 330 | 0.128 | |
| intermediate filament based process | GO:0045103 | 27 | 0.128 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.127 | |
| protein processing | GO:0016485 | 163 | 0.119 | |
| protein maturation | GO:0051604 | 176 | 0.116 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.108 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.105 | |
| placenta development | GO:0001890 | 140 | 0.098 | |
| protein citrullination | GO:0018101 | 2 | 0.097 | |
| muscle tissue development | GO:0060537 | 308 | 0.097 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.092 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.092 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.091 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.088 | |
| appendage development | GO:0048736 | 166 | 0.087 | |
| epidermis development | GO:0008544 | 187 | 0.086 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.084 | |
| regulation of keratinocyte differentiation | GO:0045616 | 11 | 0.082 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.082 | |
| lipid catabolic process | GO:0016042 | 69 | 0.081 | |
| embryonic placenta development | GO:0001892 | 98 | 0.080 | |
| regulation of protein processing | GO:0070613 | 96 | 0.074 | |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.071 | |
| muscle cell development | GO:0055001 | 133 | 0.070 | |
| striated muscle cell development | GO:0055002 | 125 | 0.067 | |
| intermediate filament organization | GO:0045109 | 15 | 0.067 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.066 | |
| hormone secretion | GO:0046879 | 128 | 0.066 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.066 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.063 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.063 | |
| response to inorganic substance | GO:0010035 | 96 | 0.060 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.059 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.059 | |
| skeletal system development | GO:0001501 | 356 | 0.058 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.057 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.056 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.055 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.055 | |
| regulation of epidermal cell differentiation | GO:0045604 | 21 | 0.055 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.054 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.054 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.053 | |
| limb development | GO:0060173 | 166 | 0.053 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.053 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.052 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.051 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.051 | |
| regulation of cell motility | GO:2000145 | 236 | 0.051 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.050 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.050 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.050 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.049 | |
| developmental maturation | GO:0021700 | 193 | 0.048 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.048 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.048 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.047 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.046 | |
| limb morphogenesis | GO:0035108 | 149 | 0.045 | |
| muscle fiber development | GO:0048747 | 76 | 0.045 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.044 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.043 | |
| cellular response to x ray | GO:0071481 | 2 | 0.043 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.043 | |
| wound healing | GO:0042060 | 157 | 0.042 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.041 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.041 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.041 | |
| protein catabolic process | GO:0030163 | 221 | 0.040 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.039 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.039 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.039 | |
| urogenital system development | GO:0001655 | 261 | 0.039 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.039 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.039 | |
| hepatocyte apoptotic process | GO:0097284 | 11 | 0.039 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.038 | |
| cell maturation | GO:0048469 | 127 | 0.038 | |
| male gamete generation | GO:0048232 | 285 | 0.038 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.038 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.037 | |
| muscle system process | GO:0003012 | 141 | 0.037 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.037 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.037 | |
| regulation of cell growth | GO:0001558 | 91 | 0.037 | |
| peptide transport | GO:0015833 | 133 | 0.037 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.037 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.036 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.036 | |
| foramen ovale closure | GO:0035922 | 1 | 0.036 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.036 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.035 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.035 | |
| tissue regeneration | GO:0042246 | 22 | 0.035 | |
| striated muscle contraction | GO:0006941 | 45 | 0.035 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.035 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.035 | |
| myotube cell development | GO:0014904 | 60 | 0.035 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.034 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.034 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.034 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.034 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.034 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.033 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.033 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.033 | |
| spermatogenesis | GO:0007283 | 284 | 0.033 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.032 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.032 | |
| myoblast differentiation | GO:0045445 | 52 | 0.032 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.032 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.032 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.032 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.031 | |
| stem cell proliferation | GO:0072089 | 117 | 0.031 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.031 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.031 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.031 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.031 | |
| av node cell to bundle of his cell communication | GO:0086067 | 2 | 0.031 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.031 | |
| sa node cell action potential | GO:0086015 | 4 | 0.030 | |
| molting cycle | GO:0042303 | 90 | 0.030 | |
| mitochondrion organization | GO:0007005 | 134 | 0.030 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.030 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.030 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.030 | |
| glucose homeostasis | GO:0042593 | 128 | 0.029 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.029 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.029 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.029 | |
| mapk cascade | GO:0000165 | 281 | 0.029 | |
| amide transport | GO:0042886 | 138 | 0.029 | |
| compound eye development | GO:0048749 | 1 | 0.029 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.028 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.028 | |
| regulation of membrane depolarization during action potential | GO:0098902 | 1 | 0.028 | |
| tissue remodeling | GO:0048771 | 102 | 0.028 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.028 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.028 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.028 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.027 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.027 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.027 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.027 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.027 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.027 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.027 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.027 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.027 | |
| dna metabolic process | GO:0006259 | 303 | 0.026 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.026 | |
| myotube differentiation | GO:0014902 | 105 | 0.026 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.026 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.026 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.026 | |
| cellular homeostasis | GO:0019725 | 240 | 0.026 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.026 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.026 | |
| cardiac septum development | GO:0003279 | 59 | 0.026 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.026 | |
| heart morphogenesis | GO:0003007 | 178 | 0.026 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.026 | |
| skin morphogenesis | GO:0043589 | 38 | 0.026 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.026 | |
| oocyte construction | GO:0007308 | 2 | 0.025 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.025 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.025 | |
| response to nutrient levels | GO:0031667 | 109 | 0.025 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.025 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.025 | |
| regulation of defense response | GO:0031347 | 233 | 0.024 | |
| organelle fission | GO:0048285 | 170 | 0.024 | |
| respiratory tube development | GO:0030323 | 167 | 0.024 | |
| milk ejection | GO:0060156 | 1 | 0.024 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.024 | |
| angiogenesis | GO:0001525 | 201 | 0.024 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.024 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.023 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.023 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.023 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.023 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.023 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.023 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.023 | |
| transition metal ion transport | GO:0000041 | 38 | 0.022 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.022 | |
| cell fate commitment | GO:0045165 | 210 | 0.022 | |
| regulation of system process | GO:0044057 | 200 | 0.022 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.022 | |
| neuronal action potential | GO:0019228 | 54 | 0.022 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.022 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.022 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.022 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.022 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.022 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.022 | |
| oocyte axis specification | GO:0007309 | 2 | 0.021 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.021 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.021 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.021 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.021 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.021 | |
| hair cycle | GO:0042633 | 90 | 0.021 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.021 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.021 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.021 | |
| cell growth | GO:0016049 | 130 | 0.021 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.021 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.020 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.020 | |
| cellular response to starvation | GO:0009267 | 57 | 0.020 | |
| palate development | GO:0060021 | 76 | 0.020 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.020 | |
| lipid homeostasis | GO:0055088 | 63 | 0.020 | |
| response to growth factor | GO:0070848 | 198 | 0.020 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.020 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.020 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.020 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.020 | |
| connective tissue development | GO:0061448 | 179 | 0.020 | |
| organ growth | GO:0035265 | 117 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.020 | |
| amine metabolic process | GO:0009308 | 45 | 0.020 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.020 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.020 | |
| response to peptide | GO:1901652 | 136 | 0.020 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.020 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.020 | |
| regeneration | GO:0031099 | 38 | 0.020 | |
| reflex | GO:0060004 | 22 | 0.019 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.019 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.019 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.019 | |
| regulation of ossification | GO:0030278 | 112 | 0.019 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.019 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.019 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.019 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.019 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.019 | |
| oxidation reduction process | GO:0055114 | 342 | 0.019 | |
| anion transport | GO:0006820 | 177 | 0.019 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.019 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.019 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.018 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.018 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.018 | |
| circulatory system process | GO:0003013 | 197 | 0.018 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.018 | |
| mesenchyme development | GO:0060485 | 152 | 0.018 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.018 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.018 | |
| cardiac chamber development | GO:0003205 | 108 | 0.018 | |
| cartilage development | GO:0051216 | 140 | 0.018 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.018 | |
| lung development | GO:0030324 | 164 | 0.018 | |
| fertilization | GO:0009566 | 127 | 0.018 | |
| sterol homeostasis | GO:0055092 | 45 | 0.018 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.018 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.018 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.018 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.018 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.017 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.017 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.017 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.017 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.017 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.017 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.017 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.017 | |
| septum primum development | GO:0003284 | 4 | 0.017 | |
| hair follicle development | GO:0001942 | 85 | 0.017 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.017 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.017 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.017 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.017 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.017 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.017 | |
| peptide secretion | GO:0002790 | 114 | 0.017 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.017 | |
| regulation of phosphatidylcholine biosynthetic process | GO:2001245 | 2 | 0.017 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.017 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.017 | |
| response to acid chemical | GO:0001101 | 111 | 0.017 | |
| cerebellum development | GO:0021549 | 77 | 0.017 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.017 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.017 | |
| blood coagulation | GO:0007596 | 76 | 0.017 | |
| regulation of cell migration | GO:0030334 | 219 | 0.017 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.017 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.017 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.016 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.016 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.016 | |
| response to metal ion | GO:0010038 | 47 | 0.016 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.016 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.016 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.016 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.016 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.016 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.016 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.016 | |
| ear development | GO:0043583 | 200 | 0.016 | |
| negative regulation of keratinocyte differentiation | GO:0045617 | 4 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.016 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.016 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.016 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.016 | |
| positive regulation of cell growth | GO:0030307 | 33 | 0.016 | |
| inflammatory response | GO:0006954 | 244 | 0.016 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.016 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.016 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.016 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.016 | |
| insulin secretion | GO:0030073 | 89 | 0.015 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.015 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.015 | |
| epithelial cell development | GO:0002064 | 159 | 0.015 | |
| bone development | GO:0060348 | 120 | 0.015 | |
| stem cell development | GO:0048864 | 219 | 0.015 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.015 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.015 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.015 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.015 | |
| spongiotrophoblast layer development | GO:0060712 | 15 | 0.015 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.015 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.015 | |
| regulation of wound healing | GO:0061041 | 40 | 0.015 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.015 | |
| mesonephros development | GO:0001823 | 97 | 0.015 | |
| primary neural tube formation | GO:0014020 | 95 | 0.015 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.015 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.015 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.015 | |
| response to starvation | GO:0042594 | 65 | 0.014 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.014 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.014 | |
| blastocyst development | GO:0001824 | 80 | 0.014 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.014 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.014 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.014 | |
| tube closure | GO:0060606 | 91 | 0.014 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.014 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.014 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.014 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.014 | |
| axonogenesis | GO:0007409 | 274 | 0.014 | |
| hindbrain development | GO:0030902 | 128 | 0.014 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.014 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.014 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.014 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.014 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.014 | |
| response to radiation | GO:0009314 | 165 | 0.014 | |
| steroid metabolic process | GO:0008202 | 119 | 0.014 | |
| exocytosis | GO:0006887 | 121 | 0.014 | |
| actin filament organization | GO:0007015 | 113 | 0.014 | |
| regulation of water loss via skin | GO:0033561 | 16 | 0.014 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.014 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.014 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.014 | |
| camera type eye development | GO:0043010 | 266 | 0.014 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.014 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.014 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.014 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.014 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.014 | |
| zymogen activation | GO:0031638 | 41 | 0.014 | |
| muscle contraction | GO:0006936 | 101 | 0.014 | |
| neural tube formation | GO:0001841 | 108 | 0.014 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.014 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.013 | |
| odontogenesis | GO:0042476 | 78 | 0.013 | |
| cell division | GO:0051301 | 120 | 0.013 | |
| interleukin 8 production | GO:0032637 | 4 | 0.013 | |
| positive regulation of growth | GO:0045927 | 104 | 0.013 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.013 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.013 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.013 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.013 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.013 | |
| positive regulation of epidermis development | GO:0045684 | 13 | 0.013 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.013 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.013 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.013 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.013 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.013 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.013 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.013 | |
| keratinization | GO:0031424 | 9 | 0.013 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.013 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.013 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.013 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.013 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.013 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.013 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.013 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.013 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.013 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.013 | |
| cellular modified amino acid biosynthetic process | GO:0042398 | 12 | 0.013 | |
| spermatid differentiation | GO:0048515 | 115 | 0.013 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.013 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.013 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.013 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.012 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.012 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.012 | |
| alpha amino acid biosynthetic process | GO:1901607 | 15 | 0.012 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.012 | |
| artery development | GO:0060840 | 53 | 0.012 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.012 | |
| ossification | GO:0001503 | 216 | 0.012 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.012 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.012 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.012 | |
| forebrain development | GO:0030900 | 302 | 0.012 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.012 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.012 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.012 | |
| segmentation | GO:0035282 | 93 | 0.012 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.012 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.012 | |
| nuclear transport | GO:0051169 | 139 | 0.012 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.012 | |
| protein ubiquitination | GO:0016567 | 171 | 0.012 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.012 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.012 | |
| cell adhesion | GO:0007155 | 329 | 0.012 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.012 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.012 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.012 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.012 | |
| methylation | GO:0032259 | 134 | 0.012 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.012 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.012 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.012 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.012 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.012 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.012 | |
| regulation of protein transport | GO:0051223 | 163 | 0.012 | |
| coagulation | GO:0050817 | 78 | 0.011 | |
| liver development | GO:0001889 | 66 | 0.011 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.011 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.011 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.011 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.011 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.011 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.011 | |
| actin filament based movement | GO:0030048 | 23 | 0.011 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.011 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.011 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.011 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.011 | |
| cytokine production | GO:0001816 | 319 | 0.011 | |
| protein localization to organelle | GO:0033365 | 185 | 0.011 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.011 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.011 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.011 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.011 | |
| spermatid development | GO:0007286 | 108 | 0.011 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.011 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.011 | |
| regulation of membrane depolarization during cardiac muscle cell action potential | GO:1900825 | 1 | 0.011 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.011 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.011 | |
| telencephalon development | GO:0021537 | 186 | 0.011 | |
| renal vesicle induction | GO:0072034 | 3 | 0.011 | |
| negative regulation of lymphocyte apoptotic process | GO:0070229 | 24 | 0.011 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.011 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.011 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.011 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.011 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.011 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.011 | |
| chromatin organization | GO:0006325 | 206 | 0.011 | |
| endodermal digestive tract morphogenesis | GO:0061031 | 4 | 0.011 | |
| mesoderm development | GO:0007498 | 100 | 0.011 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.011 | |
| dephosphorylation | GO:0016311 | 129 | 0.011 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.011 | |
